April 6, 2025 - 18:46

Tariffs will be at the center of the market action in the week ahead as Trump's latest announcements have sent stocks reeling. The past week marked the worst performance for the stock market since 2020, with investors reacting sharply to the potential implications of new tariffs on international trade. Analysts suggest that heightened trade tensions could lead to increased costs for consumers and businesses alike, further complicating an already fragile economic recovery.
As traders brace for the upcoming week, many are closely monitoring developments related to tariff policies. The uncertainty surrounding these measures has led to increased volatility, prompting investors to reassess their strategies. Major indices have experienced significant fluctuations, raising concerns about the long-term impact on growth and stability.
Market experts warn that if tariffs escalate, sectors heavily reliant on imports could face significant challenges. Consequently, investors are advised to stay informed and consider the potential ramifications on their portfolios as the situation unfolds.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...